DK1259226T3 - Anæstetiske formuleringer - Google Patents

Anæstetiske formuleringer

Info

Publication number: DK1259226T3
Authority: DK; Denmark
Prior art keywords: anesthetic formulations; propofol; preparations; anesthetic; formulations
Prior art date: 2000-02-29

Application number

DK01907943T

Other languages

English (en)

Inventor

John Meadows

Mayne James David Du

Original Assignee

Maelor Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-29

Filing date

2001-02-28

Publication date

2006-08-21

2001-02-28 Application filed by Maelor Pharmaceuticals Ltd filed Critical Maelor Pharmaceuticals Ltd

2006-08-21 Application granted granted Critical

2006-08-21 Publication of DK1259226T3 publication Critical patent/DK1259226T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Anesthesiology (AREA)
Dispersion Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK01907943T 2000-02-29 2001-02-28 Anæstetiske formuleringer DK1259226T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB0004841A GB2359747B (en)	2000-02-29	2000-02-29	Anaesthetic formulations

Publications (1)

Publication Number	Publication Date
DK1259226T3 true DK1259226T3 (da)	2006-08-21

Family

ID=9886669

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01907943T DK1259226T3 (da)	2000-02-29	2001-02-28	Anæstetiske formuleringer

Country Status (21)

Country	Link
US (2)	US7166303B2 (da)
EP (1)	EP1259226B1 (da)
JP (1)	JP4215430B2 (da)
KR (1)	KR100652552B1 (da)
CN (1)	CN100376232C (da)
AT (1)	ATE324101T1 (da)
AU (2)	AU3580901A (da)
BR (1)	BR0108738A (da)
CA (1)	CA2401089C (da)
CZ (1)	CZ300790B6 (da)
DE (1)	DE60119082T2 (da)
DK (1)	DK1259226T3 (da)
ES (1)	ES2262628T3 (da)
GB (1)	GB2359747B (da)
HU (1)	HU226485B1 (da)
IL (2)	IL151311A0 (da)
NO (1)	NO20024095L (da)
NZ (1)	NZ520765A (da)
RU (1)	RU2250101C2 (da)
WO (1)	WO2001064187A2 (da)
ZA (1)	ZA200206233B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000010531A1 (en)	1998-08-19	2000-03-02	Rtp Pharma Inc.	Injectable aqueous dispersions of propofol
CN1149984C (zh) *	1999-06-21	2004-05-19	健一制药株式会社	用于静脉注射的含有普鲁泊福的麻醉组合物
GB2359747B (en) *	2000-02-29	2002-04-24	Maelor Pharmaceuticals Ltd	Anaesthetic formulations
US6939564B2 (en)	2001-06-08	2005-09-06	Labopharm, Inc.	Water-soluble stabilized self-assembled polyelectrolytes
GB0120701D0 (en) *	2001-08-24	2001-10-17	Maelor Pharmaceuticals Ltd	Pharmaceutical formulations
GB0120702D0 (en) *	2001-08-24	2001-10-17	Maelor Pharmaceuticals Ltd	Anaesthetic formulations
GB0124071D0 (en) *	2001-10-08	2001-11-28	Kbig Ltd	Improvement in the administration of high boiling point aneasthetics
IL164217A0 (en) *	2002-04-08	2005-12-18	Guilford Pharm Inc	Pharmaceutical compositions containing water-soluble propofol and methods of administering same
US7550155B2 (en)	2002-07-29	2009-06-23	Transform Pharmaceuticals Inc.	Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
KR101145692B1 (ko) *	2002-07-29	2012-05-25	트렌스폼 파마수티컬스 인코퍼레이티드	수성 2,6-디이소프로필페놀 약제학적 조성물
US8476010B2 (en)	2003-07-10	2013-07-02	App Pharmaceuticals Llc	Propofol formulations with non-reactive container closures
GB0327390D0 (en) *	2003-11-25	2003-12-31	Pfizer Ltd	Pharmaceutical formulations
WO2005079758A1 (en) *	2004-02-13	2005-09-01	Bioavailability, Inc.	A microemulsion preparation of high concentration propofol for anesthetic uses
US20060198891A1 (en) *	2004-11-29	2006-09-07	Francois Ravenelle	Solid formulations of liquid biologically active agents
PL1906921T3 (pl) *	2005-07-08	2009-06-30	Physica Pharma	Klarowna wodna mikroemulsja farmaceutyczna zawierająca propofol i sposób jej wytwarzania
WO2007108505A1 (ja) *	2006-03-22	2007-09-27	Chugai Seiyaku Kabushiki Kaisha	エリスロポエチン溶液製剤
CN100579510C (zh) *	2006-04-13	2010-01-13	新疆维吾尔自治区包虫病临床研究所	新型前体胶束制剂及其生产方法
MX2009003092A (es) *	2006-09-22	2009-05-08	Labopharm Inc	Composiciones y metodos para suministro de farmaco dirigido a ph.
KR20080102010A (ko) *	2007-05-17	2008-11-24	대원제약주식회사	프로포폴을 포함하는 주사제용 조성물 및 이의 제조 방법
WO2010088924A1 (en) *	2009-02-06	2010-08-12	Telormedix Sa	Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
WO2012151544A1 (en) *	2011-05-05	2012-11-08	Wisconsin Alumni Research Foundation	Micelles for the solubilization of gossypol
RU2535001C1 (ru) *	2013-07-11	2014-12-10	Общество с ограниченной ответственностью "ВИК-здоровье животных"	Микроколлоидный раствор пропофола для анестезии
JP6235755B2 (ja)	2014-07-02	2017-11-22	ザリサーチファウンデイションフォーザステイトユニバーシティーオブニューヨーク	高いカーゴ対サーファクタント比を有するサーファクタント除去ミセル組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1472793A (en) *	1974-03-28	1977-05-04	Ici Ltd	Pharmaceutical compositions
DE4039602A1 (de) *	1990-12-12	1992-06-17	Bauer Kurt Heinz Prof Dr	Pharmazeutische formulierungen
US5916596A (en) *	1993-02-22	1999-06-29	Vivorx Pharmaceuticals, Inc.	Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
GB9405593D0 (en)	1994-03-22	1994-05-11	Zeneca Ltd	Pharmaceutical compositions
US5635536A (en) *	1994-12-07	1997-06-03	Pharmacia & Upjohn Aktiebolag	Emulsion suitable for administering a sphingolipid
US5637625A (en) *	1996-03-19	1997-06-10	Research Triangle Pharmaceuticals Ltd.	Propofol microdroplet formulations
WO2000010531A1 (en) *	1998-08-19	2000-03-02	Rtp Pharma Inc.	Injectable aqueous dispersions of propofol
CN1149984C (zh) *	1999-06-21	2004-05-19	健一制药株式会社	用于静脉注射的含有普鲁泊福的麻醉组合物
US6264981B1 (en) *	1999-10-27	2001-07-24	Anesta Corporation	Oral transmucosal drug dosage using solid solution
GB2359747B (en) *	2000-02-29	2002-04-24	Maelor Pharmaceuticals Ltd	Anaesthetic formulations

2000
- 2000-02-29 GB GB0004841A patent/GB2359747B/en not_active Expired - Fee Related
2001
- 2001-02-28 BR BR0108738-0A patent/BR0108738A/pt not_active Application Discontinuation
- 2001-02-28 EP EP01907943A patent/EP1259226B1/en not_active Expired - Lifetime
- 2001-02-28 KR KR1020027011354A patent/KR100652552B1/ko not_active IP Right Cessation
- 2001-02-28 IL IL15131101A patent/IL151311A0/xx active IP Right Grant
- 2001-02-28 CA CA2401089A patent/CA2401089C/en not_active Expired - Fee Related
- 2001-02-28 CZ CZ20022914A patent/CZ300790B6/cs not_active IP Right Cessation
- 2001-02-28 RU RU2002123180/15A patent/RU2250101C2/ru not_active IP Right Cessation
- 2001-02-28 DK DK01907943T patent/DK1259226T3/da active
- 2001-02-28 US US10/203,737 patent/US7166303B2/en not_active Expired - Fee Related
- 2001-02-28 CN CNB018058361A patent/CN100376232C/zh not_active Expired - Fee Related
- 2001-02-28 AU AU3580901A patent/AU3580901A/xx active Pending
- 2001-02-28 NZ NZ520765A patent/NZ520765A/en unknown
- 2001-02-28 AT AT01907943T patent/ATE324101T1/de not_active IP Right Cessation
- 2001-02-28 ES ES01907943T patent/ES2262628T3/es not_active Expired - Lifetime
- 2001-02-28 DE DE60119082T patent/DE60119082T2/de not_active Expired - Lifetime
- 2001-02-28 WO PCT/GB2001/000868 patent/WO2001064187A2/en active IP Right Grant
- 2001-02-28 AU AU2001235809A patent/AU2001235809B2/en not_active Ceased
- 2001-02-28 HU HU0300125A patent/HU226485B1/hu not_active IP Right Cessation
- 2001-02-28 JP JP2001563084A patent/JP4215430B2/ja not_active Expired - Fee Related
2002
- 2002-08-05 ZA ZA200206233A patent/ZA200206233B/xx unknown
- 2002-08-18 IL IL151311A patent/IL151311A/en not_active IP Right Cessation
- 2002-08-28 NO NO20024095A patent/NO20024095L/no not_active Application Discontinuation
2006
- 2006-12-18 US US11/612,176 patent/US20070122467A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1259226B1 (en)	2006-04-26
CA2401089C (en)	2011-01-18
EP1259226A2 (en)	2002-11-27
JP4215430B2 (ja)	2009-01-28
GB2359747A (en)	2001-09-05
ZA200206233B (en)	2003-11-05
NO20024095L (no)	2002-10-23
RU2002123180A (ru)	2004-03-20
CA2401089A1 (en)	2001-09-07
JP2003525231A (ja)	2003-08-26
KR100652552B1 (ko)	2006-11-30
WO2001064187B1 (en)	2002-03-07
IL151311A (en)	2007-10-31
IL151311A0 (en)	2003-04-10
RU2250101C2 (ru)	2005-04-20
KR20030011781A (ko)	2003-02-11
AU2001235809B2 (en)	2004-08-05
AU3580901A (en)	2001-09-12
GB2359747B (en)	2002-04-24
HUP0300125A3 (en)	2003-09-29
HUP0300125A2 (hu)	2003-07-28
DE60119082T2 (de)	2006-11-30
CN1416337A (zh)	2003-05-07
CZ300790B6 (cs)	2009-08-12
WO2001064187A2 (en)	2001-09-07
US20070122467A1 (en)	2007-05-31
CN100376232C (zh)	2008-03-26
US7166303B2 (en)	2007-01-23
WO2001064187A8 (en)	2002-10-03
NZ520765A (en)	2003-07-25
ATE324101T1 (de)	2006-05-15
CZ20022914A3 (cs)	2003-01-15
ES2262628T3 (es)	2006-12-01
BR0108738A (pt)	2002-12-17
GB0004841D0 (en)	2000-04-19
HU226485B1 (en)	2009-03-02
US20030138489A1 (en)	2003-07-24
NO20024095D0 (no)	2002-08-28
WO2001064187A3 (en)	2002-01-03
DE60119082D1 (de)	2006-06-01

Publication	Publication Date	Title
DK1259226T3 (da)	2006-08-21	Anæstetiske formuleringer
CR7614A (es)	2005-06-16	Preparaciones de insulina acida con estabilidad mejorada
ATE382057T1 (de)	2008-01-15	Stabile formulierung von modifiziertem glp-1
CY1108532T1 (el)	2014-04-09	Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
ATE415943T1 (de)	2008-12-15	Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff
ATE398997T1 (de)	2008-07-15	Selbst-nanoemulgierende ölige formulierung zur verabreichung von schwer wasserlöslichen arzneimitteln
DE69901726D1 (de)	2002-07-11	Stabile konzentrierte insulin präparationen zur pulmonaren verabreichung
ATE146358T1 (de)	1997-01-15	Stabilisierung von fluorkohlenstoff-emulsionen
EP1226109A4 (en)	2005-01-26	PHENYLAMINE CARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS FOR DISPENSING ACTIVE AGENTS
BR0107869A (pt)	2002-11-05	Composições farmacêuticas eletrogiradas
DE69629989D1 (de)	2003-10-23	Präparate zur äusserlichen anwendung zur behandlung von dermatosen
DE69521693D1 (de)	2001-08-16	Taxanderivate enthaltende arzneizubereitungen
SE9800729L (sv)	1999-09-07	Ny topikal formulering I
EE9900612A (et)	2000-08-15	Inimese papilloomiviiruse stabiliseeritud preparaadid
NO20043001D0 (no)	2004-07-13	Farmasoytisk formulering omfattende cyklosporin og anvendelse derav
DE60207266D1 (de)	2005-12-15	Anaesthetische propofol zubereitungen
ATE395064T1 (de)	2008-05-15	Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
ATE380543T1 (de)	2007-12-15	Stabilisierung von festen schilddrüsenhormonzusammensetzungen
NZ521533A (en)	2003-03-28	Veterinary compositions for the treatment of parasitic diseases containing rafoxanide
DE60135845D1 (de)	2008-10-30	Pralmorelin-haltige nasentropfen-präparate
ATE301453T1 (de)	2005-08-15	Injizierbare arzneiformulierungen von partricin derivaten
RU97113620A (ru)	1999-06-20	Ранозаживляющая мазь "эпофен"
CL2015003413A1 (es)	2016-05-27	Formulación estable que comprende la proteína iduronato-2-sulfatasa y un tensoactico de polisorbato; contenedor que comprende dicha formulación; uso de dicha formulación para tratar síndrome de hunters.